Published in J Am Coll Cardiol on April 02, 2003
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest (2010) 3.09
Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Stem cell therapy is proarrhythmic. Circulation (2009) 1.83
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J (2011) 1.80
Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol (2009) 1.64
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood (2006) 1.63
Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc (2009) 1.62
Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol (2012) 1.60
Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest (2010) 1.57
Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res (2008) 1.54
Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo. J Thorac Cardiovasc Surg (2014) 1.44
Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest (2004) 1.38
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med (2012) 1.30
Electrophysiological challenges of cell-based myocardial repair. Circulation (2009) 1.30
Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol (2006) 1.28
Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. Am J Physiol Heart Circ Physiol (2008) 1.28
Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol (2004) 1.26
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One (2011) 1.22
Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm (2008) 1.19
Update on therapeutic vascularization strategies. Regen Med (2009) 1.17
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med (2006) 1.13
Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res (2014) 1.09
Focal gap junction uncoupling and spontaneous ventricular ectopy. Am J Physiol Heart Circ Physiol (2005) 1.08
Bone marrow mononuclear stem cells transplanted in rat infarct myocardium improved the electrical conduction without evidence of proarrhythmic effects. Yonsei Med J (2007) 1.05
Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol (2007) 1.05
Heart repair and stem cells. J Physiol (2006) 1.04
Current perspectives on imaging cardiac stem cell therapy. J Nucl Med (2010) 1.00
Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study. Mol Ther (2013) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Micro- and nanoscale control of the cardiac stem cell niche for tissue fabrication. Tissue Eng Part B Rev (2009) 0.97
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med (2011) 0.95
Getting to the heart of myocardial stem cells and cell therapy. Circulation (2011) 0.95
Skeletal myoblasts for cardiac repair. Regen Med (2010) 0.95
Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol (2008) 0.94
Angiomyogenesis for myocardial repair. Antioxid Redox Signal (2009) 0.93
Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med (2009) 0.93
Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int (2012) 0.92
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev (2011) 0.91
Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharm (2011) 0.91
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review. JAMA Cardiol (2016) 0.90
The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg (2009) 0.90
Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? Stem Cell Res Ther (2013) 0.90
Stem cell therapy for cardiac dysfunction. Springerplus (2014) 0.90
Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure. J Cardiothorac Surg (2006) 0.90
Lessons for cardiac regeneration and repair through development. Trends Mol Med (2010) 0.89
Ventricular scars and ventricular tachycardia. Trans Am Clin Climatol Assoc (2009) 0.89
The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J Heart Lung Transplant (2008) 0.89
c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes. Clin Transl Sci (2009) 0.89
Cardiac repair with adult bone marrow-derived cells: the clinical evidence. Antioxid Redox Signal (2009) 0.88
Organotypic heart slices for cell transplantation and physiological studies. Organogenesis (2009) 0.88
MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. Curr Opin Mol Ther (2008) 0.88
Calcium signalling of human pluripotent stem cell-derived cardiomyocytes. J Physiol (2013) 0.87
Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. Int J Med Sci (2013) 0.87
Stem celltherapy for ischemic heart failure. Tex Heart Inst J (2005) 0.87
Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells Int (2011) 0.86
Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? Neth Heart J (2012) 0.86
Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circ Cardiovasc Interv (2013) 0.86
Cardiac regeneration using pluripotent stem cells--progression to large animal models. Stem Cell Res (2014) 0.86
Stem cells for stress urinary incontinence: the adipose promise. J Cell Mol Med (2009) 0.86
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy. Stem Cells Int (2015) 0.86
Myoangiogenesis after cell patch cardiomyoplasty and omentopexy in a patient with ischemic cardiomyopathy. Tex Heart Inst J (2005) 0.85
Stem cell therapy for heart failure. Methodist Debakey Cardiovasc J (2013) 0.85
Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol (2006) 0.85
Enhanced gap junction expression in myoblast-containing engineered tissue. Biochem Biophys Res Commun (2012) 0.85
Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol (2003) 0.85
Endothelial cells regulate cardiomyocyte development from embryonic stem cells. J Cell Biochem (2010) 0.85
Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci (2007) 0.84
Stem cell differentiation: cardiac repair. Cells Tissues Organs (2007) 0.84
More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair. Circ Res (2016) 0.84
Cell-based approaches for cardiac repair. Ann N Y Acad Sci (2006) 0.84
Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc Disord (2006) 0.84
Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease. Interact Cardiovasc Thorac Surg (2013) 0.84
Moving beyond surrogate endpoints in cell therapy trials for heart disease. Stem Cells Transl Med (2013) 0.82
Present and future perspectives on cell sheet-based myocardial regeneration therapy. Biomed Res Int (2013) 0.82
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease. Am J Physiol Heart Circ Physiol (2015) 0.81
Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival. PLoS One (2013) 0.81
Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques. Imaging Med (2011) 0.81
Aesthetic cardiology: adipose-derived stem cells for myocardial repair. Curr Stem Cell Res Ther (2010) 0.80
Surgical aspects of congestive heart failure. Heart Fail Rev (2006) 0.80
Personalized cardiac regeneration by stem cells-Hype or hope? EPMA J (2011) 0.80
Impact of synovial membrane-derived stem cell transplantation in a rat model of myocardial infarction. J Artif Organs (2009) 0.80
Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. Heart Fail Rev (2007) 0.80
Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells. Stem Cells Int (2016) 0.80
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes. J Cell Mol Med (2010) 0.80
Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair. Stem Cells Transl Med (2013) 0.80
Time Course of Cell Sheet Adhesion to Porcine Heart Tissue after Transplantation. PLoS One (2015) 0.79
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol (2011) 5.63
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res (2011) 5.30
Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85
Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med (2005) 4.85
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study. Lancet (2012) 4.03
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol (2009) 3.97
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity (2013) 3.50
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) (2004) 2.81
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest (2012) 2.61
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res (2006) 2.56
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res (2012) 2.43
Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res (2009) 2.37
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet (2004) 2.31
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol (2014) 2.23
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int (2010) 2.22
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Cardiac stem cells in the real world. J Thorac Cardiovasc Surg (2008) 2.19
Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest (2002) 2.17
Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med (2008) 2.17
Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med (2006) 2.16
Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med (2010) 2.15
Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. J Thorac Cardiovasc Surg (2012) 2.07
Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium? Interact Cardiovasc Thorac Surg (2007) 2.07
A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest (2010) 2.06
Sports-related sudden death in the general population. Circulation (2011) 2.06
Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol (2008) 2.03
Deep hypothermia and low flow for surgery for abdominal or extraperitoneal tumors with cavoatrial extension. Ann Thorac Surg (2013) 2.01
Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology (2009) 2.01
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol (2007) 1.90
High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med (2003) 1.80
Parietal podocytes in normal human glomeruli. J Am Soc Nephrol (2006) 1.79
Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol (2004) 1.79
Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg (2009) 1.76
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant (2008) 1.76
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies. J Clin Oncol (2012) 1.74
Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg (2003) 1.74
Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol (2011) 1.73
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling. Circulation (2012) 1.68
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation (2006) 1.63
Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J (2009) 1.61
Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res (2003) 1.60
Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA (2012) 1.58
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A (2011) 1.55
Tracheal replacement with cryopreserved, decellularized, or glutaraldehyde-treated aortic allografts. Ann Thorac Surg (2009) 1.55
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int (2010) 1.54
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J (2008) 1.54
Evidence of leaflet injury during percutaneous aortic valve deployment. Eur J Cardiothorac Surg (2010) 1.52
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol (2011) 1.51
Mapping myocardial fiber orientation using echocardiography-based shear wave imaging. IEEE Trans Med Imaging (2011) 1.49
Quantitative assessment of arterial wall biomechanical properties using shear wave imaging. Ultrasound Med Biol (2010) 1.49
Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol (2003) 1.48
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood (2002) 1.46
Carinal replacement with an aortic allograft. Ann Thorac Surg (2006) 1.46
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford) (2012) 1.45
Performance assessment of a chest pain unit: Preliminary 2-year experience in the European Georges Pompidou Hospital. Arch Cardiovasc Dis (2009) 1.45
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail (2006) 1.45
Prorenin contributes to angiotensin peptide formation in transgenic rats with rat prorenin expression targeted to the liver. Hypertension (2009) 1.44
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 1.43
Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice. Hypertension (2013) 1.43
Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol (2008) 1.41
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry (2012) 1.39
Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest. Crit Care Med (2015) 1.39
High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis (2004) 1.39
Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res (2004) 1.39
Traumatic leaflet injury during the use of percutaneous valves: a comparative study of balloon- and self-expandable valved stents. Eur J Cardiothorac Surg (2012) 1.38
A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther (2002) 1.37
Major regional disparities in outcomes after sudden cardiac arrest during sports. Eur Heart J (2013) 1.35
Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr (2002) 1.32
In vivo quantitative mapping of myocardial stiffening and transmural anisotropy during the cardiac cycle. IEEE Trans Med Imaging (2010) 1.29
Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res (2014) 1.29
Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation (2002) 1.27